Aspen Neuroscience (ASPE) news
Recent news
Aspen Neuroscience opens at $14.70, IPO at $15
Aspen Neuroscience (ASPE) made its initial public offering (IPO) on October 30, 2026, with a listing price of $15 per share. However, the stock opened at $14.70, slightly below the IPO price, reflecting early market dynamics and investor sentiment. The company, which focuses on developing cell…
AInvest Wire · 3h agoAspen Neuroscience shares indicated at $15; IPO price $15
Aspen Neuroscience (NASDAQ: ASPE) launched its initial public offering (IPO) on October 26, 2026, with shares priced at $15 per share, aligning with the lower end of its expected range . The company is marketing 9.38 million shares as part of the offering, aiming to raise up to $155 million in…
AInvest Wire · 4h agoAspen Neuroscience prices IPO at $15.00/share
Aspen Neuroscience (ASPE Proposed) has priced its initial public offering (IPO) at $15.00 per share, according to recent filings and market updates. The company, which is developing autologous induced pluripotent stem cell (iPSC) therapies for neurological disorders, is seeking to advance its…
AInvest Wire · 17h agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.